Goldenwell Biotech, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €119.96 -94.1% -€113.49K +12.5% -94,602.9% -900 pp -€106.22K +7.3% -88,544.6% -840 pp
    €2.02K -95.1% -€100.88K -88.1% -4,995.5% -29 pp -€98.98K -89.3% -4,901.2% -27 pp
    €41.25K +199.4% -€850.17K +742.1% -2,060.9% -13 pp -€925.66K +422.8% -2,243.8% -9.6 pp
    €13.78K +∞% -€100.96K +1,749.8% -732.6% -7.3 pp -€177.04K +3,143.8% -1,284.8% -13 pp
    €0.00 +NaN% -€5.46K -8.8% N/A -€5.46K -8.8% N/A
    €0.00 -€5.98K N/A -€5.98K N/A

    Notifications